Sort
50,496 grants matching “lung cancer”
Preclinical Development of Therapeutics in Murine Models of Lung Cancer
$418,616Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites
$418,613Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · R01 · FY2018 · CA
Targeting Musashi-2 (MSI2) regulation of VEGFR2 / VEGF-A in lung cancer
$418,613Yanis Boumber · Research Inst Of Fox Chase Can Ctr · R01 · FY2018 · CA
Targeting the kinome in K-ras driven colorectal cancers
$418,613James Stuart Duncan · Research Inst Of Fox Chase Can Ctr · R01 · FY2017 · CA
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
$418,595Jane B Lian · University Of Vermont & St Agric College · P01 · FY2023 · CA
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
$418,569Yong Lin · Lovelace Biomedical & Environmental Research Institute · R01 · FY2013 · ES
NanoOptogenetic immunotherapy for B cell lymphoma
$418,557Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Molecular Signatures for Individualizing Lung Cancer Therapy
$418,554John D Minna · Ut Southwestern Medical Center · P50 · FY2017 · CA
Molecular Signatures for Individualizing Lung Cancer Therapy
$418,550John D Minna · Ut Southwestern Medical Center · P50 · FY2018 · CA
Femtosecond Infrared Laser Ablation Platform
$418,549Lee E Goldstein · Boston University Medical Campus · S10 · FY2010 · RR
MID ATLANTIC PROSTATE CANCER BANK
$418,545George Washington University · U01 · FY2000 · CA
Angiogenesis in the Lung
$418,520Elizabeth Wagner · Johns Hopkins University · R01 · FY2009 · HL
New Statistical Methods for Modelling Cancer Outcomes
$418,516Yi Li · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$418,484Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2025 · CA
Small molecule agonists of the relaxin 1 receptor
$418,442Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Neuroimmune Molecules in Scleroderma Lung Fibrosis
$418,295Erica L Herzog · Yale University · R01 · FY2019 · HL
Neuroimmune Molecules in Scleroderma Lung Fibrosis
$418,273Erica L Herzog · Yale University · R01 · FY2018 · HL
Electronic Cigarette-derived Oxidants and their Impact on Lung Cancer Development
$418,267Jonathan Foulds · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · CA
Basis for Lymphomagenesis in Akt2 Transgenic Mice
$418,237Joseph Robert Testa · Fox Chase Cancer Center · R01 · FY2009 · CA
Roybal Center Pilot Core
$418,212Janet Alexandria Prvu Bettger · Duke University · P30 · FY2020 · AG
Neuroimmune Molecules in Scleroderma Lung Fibrosis
$418,203Erica L Herzog · Yale University · R01 · FY2017 · HL
Tumor and Stromal Metalloproteinases in Breast Cancer
$418,177Lynn M Matrisian · Vanderbilt University · R01 · FY2006 · CA
Molecular dissection of Lkb1-mediated tumor suppression
$418,167Monte Meier Winslow · Stanford University · R01 · FY2020 · CA
Molecular dissection of Lkb1-mediated tumor suppression
$418,167Monte Meier Winslow · Stanford University · R01 · FY2021 · CA
Project 3: The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis
$418,152Don X Nguyen · Yale University · P50 · FY2025 · CA